| Factor Information | |
|---|---|
| Data ID | 503 |
| Factor | extracorporeal circulation time (ECT) |
| Description | N/A |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | diagnosis |
| Objective | patients with CHD and HT require longer extracorporeal circulation time |
| p Value | 0.02 |
| Conclusion | Our patients with CHD and HT require longer extracorporeal circulation time,more hours of intubation, and more days in the intensive care unit. Primary graft failure is more commonin patients with CHD.Therefore, survival at 1-month follow-up is lower than the rest of the series and equalizes after the year of follow-up. This long-term survival reaffirms the possibility of HT in CHD despite the fact that its postoperative period is more difficult. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 462 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | Left UVH/Right UVH/UVH/TA |
| Reference | |
|---|---|
| PMID | 29579880 |
| Year | 2018 |
| Title | Complex Congenital Heart Disease: Is Heart Transplantation an Option? |
| Sample | ||
|---|---|---|
| Population | patients older than 14 years old with CHD and HT | |
| Source | Clinical and surgical variables | |
| Region | Sevilla, Spain | |
| Method | Retrospective analysis | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | Heart transplanted surgery | |
| Group | Heart transplanted patients with CHD(Treatment) | the rest of the transplanted patients(Control) |
| Number | 10 | 428 |
| Age | 25±7 (15-36) years | N/A |
| Gender (Male: Female) | 6:4 | N/A |
| Marker Level | 235 (145-350) min | 154 (69-528) min |
